HRP20100189T1 - Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima - Google Patents
Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima Download PDFInfo
- Publication number
- HRP20100189T1 HRP20100189T1 HR20100189T HRP20100189T HRP20100189T1 HR P20100189 T1 HRP20100189 T1 HR P20100189T1 HR 20100189 T HR20100189 T HR 20100189T HR P20100189 T HRP20100189 T HR P20100189T HR P20100189 T1 HRP20100189 T1 HR P20100189T1
- Authority
- HR
- Croatia
- Prior art keywords
- solid pharmaceutical
- colloidal silicon
- weight
- pharmaceutical formulation
- silicon dioxide
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 9
- 239000000126 substance Substances 0.000 title 1
- 239000007787 solid Substances 0.000 claims abstract 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000013020 final formulation Substances 0.000 claims abstract 5
- 239000008186 active pharmaceutical agent Substances 0.000 claims abstract 4
- 150000001720 carbohydrates Chemical class 0.000 claims abstract 2
- 235000014633 carbohydrates Nutrition 0.000 claims abstract 2
- 239000003925 fat Substances 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- 102000004169 proteins and genes Human genes 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 239000003306 quinoline derived antiinfective agent Substances 0.000 claims abstract 2
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims 4
- 239000000796 flavoring agent Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229960000740 enrofloxacin Drugs 0.000 claims 3
- 235000019634 flavors Nutrition 0.000 claims 3
- 229960001248 pradofloxacin Drugs 0.000 claims 3
- LZLXHGFNOWILIY-APPDUMDISA-N pradofloxacin Chemical compound C12=C(C#N)C(N3C[C@H]4NCCC[C@H]4C3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 LZLXHGFNOWILIY-APPDUMDISA-N 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 239000008119 colloidal silica Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10351448A DE10351448A1 (de) | 2003-11-04 | 2003-11-04 | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| PCT/EP2004/012327 WO2005044271A1 (fr) | 2003-11-04 | 2004-10-30 | Formulations pharmaceutiques aromatisees presentant des proprietes pharmaceutiques ameliorees |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100189T1 true HRP20100189T1 (hr) | 2010-05-31 |
Family
ID=34559323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100189T HRP20100189T1 (hr) | 2003-11-04 | 2010-04-01 | Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US7858120B2 (fr) |
| EP (2) | EP1682144B1 (fr) |
| JP (1) | JP4892351B2 (fr) |
| KR (2) | KR20120093299A (fr) |
| CN (2) | CN1972687B (fr) |
| AR (2) | AR046226A1 (fr) |
| AT (1) | ATE454891T1 (fr) |
| AU (1) | AU2004286785B2 (fr) |
| BR (1) | BRPI0416188A (fr) |
| CA (1) | CA2544344C (fr) |
| CR (1) | CR8371A (fr) |
| CY (2) | CY1110541T1 (fr) |
| DE (2) | DE10351448A1 (fr) |
| DK (1) | DK1682144T3 (fr) |
| ES (1) | ES2337793T3 (fr) |
| HK (1) | HK1107008A1 (fr) |
| HR (1) | HRP20100189T1 (fr) |
| IL (1) | IL175147A (fr) |
| LU (1) | LU91882I2 (fr) |
| MY (1) | MY149864A (fr) |
| NO (1) | NO339326B1 (fr) |
| NZ (1) | NZ546921A (fr) |
| PE (1) | PE20050575A1 (fr) |
| PL (1) | PL1682144T3 (fr) |
| PT (1) | PT1682144E (fr) |
| RU (1) | RU2377018C2 (fr) |
| SI (1) | SI1682144T1 (fr) |
| TW (1) | TWI343819B (fr) |
| UA (1) | UA85691C2 (fr) |
| WO (1) | WO2005044271A1 (fr) |
| ZA (1) | ZA200603451B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| CN100360131C (zh) * | 2006-01-24 | 2008-01-09 | 新昌国邦化学工业有限公司 | 一种掩味恩诺沙星的生产方法 |
| DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| DE102007004732A1 (de) * | 2007-01-31 | 2008-08-07 | Bayer Healthcare Ag | Enrofloxacin-Hexahydrat |
| FR2918567B1 (fr) * | 2007-07-11 | 2012-08-03 | Pf Medicament | Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine. |
| GB0722484D0 (en) * | 2007-11-15 | 2007-12-27 | Ucl Business Plc | Solid compositions |
| DE102008022520A1 (de) * | 2008-05-07 | 2009-11-12 | Bayer Animal Health Gmbh | Feste Arzneimittelformulierung mit verzögerter Freisetzung |
| US20110223297A1 (en) * | 2010-03-12 | 2011-09-15 | Pepsico., Inc. | Anti-Caking Agent for Flavored Products |
| KR102253847B1 (ko) | 2012-12-19 | 2021-05-21 | 바이엘 애니멀 헬스 게엠베하 | 향상된 수용성 및 우수한 저장 안정성을 가지는 정제 |
| WO2015042596A1 (fr) * | 2013-09-23 | 2015-03-26 | Kindred Biosciences, Inc | Traitement de la dermite atopique chez des animaux non humains |
| JP6647395B2 (ja) * | 2016-04-27 | 2020-02-14 | 富士フイルム富山化学株式会社 | トスフロキサシントシル酸塩を含む錠剤 |
| WO2017188362A1 (fr) * | 2016-04-27 | 2017-11-02 | 富山化学工業株式会社 | Comprimé contenant de la tosufloxacine tosilate, un désintégrateur et un acide aminé acide |
| CN105997908B (zh) * | 2016-06-03 | 2019-06-21 | 湖北回盛生物科技有限公司 | 一种马波沙星牛肉风味片及其制备方法 |
| CR20200502A (es) | 2018-04-25 | 2020-12-22 | Bayer Animal Health Gmbh | Proceso para la hidrólisis de ésteres carboxílicos de quinolona |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA413698A (fr) * | 1943-07-06 | Frederick Dauster John | Soupape de respiration | |
| JPS5746986A (en) | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| US4670444B1 (en) | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
| US4472405A (en) | 1982-11-12 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
| US4730000A (en) | 1984-04-09 | 1988-03-08 | Abbott Laboratories | Quinoline antibacterial compounds |
| AT392789B (de) | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
| IN166416B (fr) | 1985-09-18 | 1990-05-05 | Pfizer | |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US4910023A (en) * | 1988-06-09 | 1990-03-20 | Warner-Lambert Company | Drug in combination with flavor masking agent and method for making same |
| US5256699A (en) | 1988-10-18 | 1993-10-26 | Ciba-Geify Corporation | Dispersible tablet formulation of diclofenac acid free base |
| GB8824392D0 (en) * | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| US5328908A (en) * | 1988-10-24 | 1994-07-12 | Procter & Gamble Pharmaceuticals, Inc. | Antimicrobial quinolone thioureas |
| JP3733140B2 (ja) | 1993-06-04 | 2006-01-11 | ワーナー−ランバート・コンパニー | 多重作用性風邪／鼻づまり製剤 |
| ES2082723B1 (es) * | 1994-07-20 | 1996-10-01 | Lilly Sa | Formulacion farmaceutica de fluoxetina en forma dispersable. |
| US5789434A (en) | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
| PT725037E (pt) | 1995-02-04 | 2001-07-31 | Degussa | Granulados a base de dioxido de silicio preparado pirogenicamente processo para a sua preparacao e sua utilizacao |
| DE59708771D1 (de) | 1996-02-23 | 2003-01-02 | Bayer Ag | Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate |
| US20010018417A1 (en) | 1996-07-01 | 2001-08-30 | Carson James W. | Virginiamycin mixture |
| GB9616536D0 (en) * | 1996-08-06 | 1996-09-25 | Quadrant Holdings Cambridge | Co-amoxiclav dosage form |
| DE19633480A1 (de) * | 1996-08-20 | 1998-02-26 | Bayer Ag | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
| CA2216215A1 (fr) * | 1997-04-05 | 1998-10-05 | Isa Odidi | Formulations a liberation prolongee, utilisant des polymeres intelligents, avec caracteristiques de mouillabilite opposees, correspondant a une hydrophobie et a une hydrophilie |
| US6607754B1 (en) * | 1997-07-11 | 2003-08-19 | Upsher-Smith Laboratories, Inc. | Delivery of Hypericum perforatum (St. John's Wort) in tablet form |
| NZ507271A (en) | 1998-03-06 | 2003-03-28 | Eurand Internat S | Fast disintegrating tablets |
| US6419953B1 (en) * | 1998-12-18 | 2002-07-16 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
| HU227070B1 (en) | 1999-08-11 | 2010-06-28 | Egis Gyogyszergyar Nyilvanosan | Immediate release pharmaceutical composition containing ciprofloxacin and process for its production |
| AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
| OA12381A (en) | 2000-03-03 | 2004-09-06 | Ranbaxy Lab Ltd | Orally administered controlled delivery system foronce daily administration of ciprofloxacin. |
| DE10031044A1 (de) | 2000-06-26 | 2002-01-03 | Bayer Ag | Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere |
| ES2185452B2 (es) * | 2000-08-01 | 2004-03-16 | Cinfa S A Lab | Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion. |
| EP1247456A3 (fr) * | 2001-02-28 | 2003-12-10 | Pfizer Products Inc. | Compositions pharmaceutiques savoureux pour les animaux domestiques |
| GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
| US20030235618A1 (en) * | 2001-10-22 | 2003-12-25 | Taro Pharmaceutical Industries Ltd. | Taste masking spill-resistant formulation |
| AU2003209673B2 (en) * | 2002-03-08 | 2007-10-18 | M/S. Ind-Swift Limited | Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof |
| US20030229101A1 (en) | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
| DE10250711A1 (de) | 2002-10-31 | 2004-05-19 | Degussa Ag | Pharmazeutische und kosmetische Zubereitungen |
| DE10351448A1 (de) * | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| PT2498756T (pt) * | 2009-11-09 | 2019-11-26 | Wyeth Llc | Formulações de comprimidos de maleato de neratinib |
-
2003
- 2003-11-04 DE DE10351448A patent/DE10351448A1/de not_active Withdrawn
-
2004
- 2004-10-30 KR KR1020127012940A patent/KR20120093299A/ko not_active Application Discontinuation
- 2004-10-30 BR BRPI0416188-2A patent/BRPI0416188A/pt not_active Application Discontinuation
- 2004-10-30 AU AU2004286785A patent/AU2004286785B2/en active Active
- 2004-10-30 EP EP04791080A patent/EP1682144B1/fr active Active
- 2004-10-30 EP EP09006259A patent/EP2080515A1/fr not_active Withdrawn
- 2004-10-30 JP JP2006538719A patent/JP4892351B2/ja active Active
- 2004-10-30 DE DE502004010644T patent/DE502004010644D1/de active Active
- 2004-10-30 CA CA2544344A patent/CA2544344C/fr active Active
- 2004-10-30 SI SI200431377T patent/SI1682144T1/sl unknown
- 2004-10-30 WO PCT/EP2004/012327 patent/WO2005044271A1/fr active Application Filing
- 2004-10-30 AT AT04791080T patent/ATE454891T1/de active
- 2004-10-30 US US10/576,408 patent/US7858120B2/en active Active
- 2004-10-30 KR KR1020067009479A patent/KR101325146B1/ko active IP Right Grant
- 2004-10-30 IL IL175147A patent/IL175147A/en active IP Right Grant
- 2004-10-30 NZ NZ546921A patent/NZ546921A/en not_active IP Right Cessation
- 2004-10-30 PL PL04791080T patent/PL1682144T3/pl unknown
- 2004-10-30 DK DK04791080.7T patent/DK1682144T3/da active
- 2004-10-30 CN CN2004800325775A patent/CN1972687B/zh active Active
- 2004-10-30 ES ES04791080T patent/ES2337793T3/es active Active
- 2004-10-30 PT PT04791080T patent/PT1682144E/pt unknown
- 2004-10-30 RU RU2006119294/15A patent/RU2377018C2/ru active
- 2004-10-30 CN CN2011102916216A patent/CN102335117A/zh active Pending
- 2004-10-30 UA UAA200606220A patent/UA85691C2/ru unknown
- 2004-11-02 AR ARP040104032A patent/AR046226A1/es not_active Application Discontinuation
- 2004-11-02 MY MYPI20044545A patent/MY149864A/en unknown
- 2004-11-03 PE PE2004001067A patent/PE20050575A1/es not_active Application Discontinuation
- 2004-11-03 TW TW093133413A patent/TWI343819B/zh not_active IP Right Cessation
-
2006
- 2006-04-27 CR CR8371A patent/CR8371A/es unknown
- 2006-05-02 ZA ZA200603451A patent/ZA200603451B/en unknown
- 2006-06-06 NO NO20062605A patent/NO339326B1/no unknown
-
2007
- 2007-11-16 HK HK07112557.3A patent/HK1107008A1/xx not_active IP Right Cessation
-
2010
- 2010-02-04 CY CY20101100111T patent/CY1110541T1/el unknown
- 2010-04-01 HR HR20100189T patent/HRP20100189T1/hr unknown
- 2010-11-19 US US12/949,833 patent/US20110065719A1/en not_active Abandoned
-
2011
- 2011-10-11 CY CY2011017C patent/CY2011017I2/el unknown
- 2011-10-12 LU LU91882C patent/LU91882I2/fr unknown
-
2017
- 2017-05-24 AR ARP170101423A patent/AR108594A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100189T1 (hr) | Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima | |
| AU666509B2 (en) | Intrabuccally disintegrating preparation and production thereof | |
| ES2350029T3 (es) | Pellets de liberación sostenida que comprenden un material tipo cera. | |
| JP5177447B2 (ja) | 速溶性及び可撓性を有するフィルム製剤 | |
| US20050147672A1 (en) | Tablets quickly disintegrating in mouth | |
| BRPI0820520B8 (pt) | processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos | |
| BRPI0417043A (pt) | composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição | |
| CA2481848A1 (fr) | Particules d'ingredients actifs comprenant du clopidogrel ou un sel, leurs utilisations et procede de preparation | |
| BRPI0406996A (pt) | Formas de dosagem sólida via transmucosa oral sem açúcar e sua utilização | |
| HUP0301252A2 (hu) | Keményítőalapú endoparaziticid szerek és eljárás ezek előállítására | |
| PT1207756E (pt) | Utilizacao de espinosade ou de uma formulacao que compreende espinosade | |
| Nandy et al. | An overview on fast dissolving drug delivery system | |
| KR20050070079A (ko) | 수용성 멜록시캄 과립 | |
| RS49703B (sr) | Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba | |
| NO20052408L (no) | Farmasoytisk formulering av olanzapin | |
| RS55392B1 (sr) | Brzo topljiva formulacija za oralno doziranje | |
| JP5054940B2 (ja) | 錠剤組成物 | |
| CZ20022886A3 (cs) | Prostředek proti endoparasitům | |
| CA2543857C (fr) | Films auto-sustentateurs pour utilisation pharmaceutique et alimentaire | |
| CA2380757A1 (fr) | Agent pharmaceutique comprenant un derive benzamide comme principe actif | |
| BR0312206A (pt) | Formulações de pélete esférico | |
| US20150072014A1 (en) | Pharmaceutical Compositions of Sodium Picosulfate, Magnesium Oxide and Citric Acid | |
| DE60319983D1 (de) | Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan | |
| JP2001072578A (ja) | 口腔内速崩壊錠 | |
| JP2006522804A (ja) | 獣医学的使用のための経口投与剤形 |